Eikon Therapeutics, Inc. eyes IPO to fund EIK1001 oncology pipeline; early Phase 2 data show 60% response rate. Click for ...
As the result emerges in the Kenyan presidential election, Reuters news and analysis features in Decision Africa, a dedicated app for Eikon, the flagship financial product from Thomson Reuters. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback